{"id":123881,"date":"2021-07-23T17:50:00","date_gmt":"2021-07-23T17:50:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2894711"},"modified":"2021-07-23T17:50:00","modified_gmt":"2021-07-23T17:50:00","slug":"hospital-acquired-disease-testing-market-analysis-recent-trends-and-growth-forecast-by-2026","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/07\/23\/hospital-acquired-disease-testing-market-analysis-recent-trends-and-growth-forecast-by-2026\/","title":{"rendered":"Hospital Acquired Disease Testing Market Analysis, Recent Trends and Growth Forecast by 2026"},"content":{"rendered":"

According to the latest report by IMARC Group, titled “Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026<\/strong>”, the global hospital acquired disease testing market<\/a><\/strong> reached a value of US$ 7.32 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026.<\/p>\n

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.<\/p>\n

Request Free Report Sample:<\/strong><\/p>\n

https:\/\/www.imarcgroup.com\/hospital-acquired-disease-testing-market\/requestsample<\/a><\/p>\n

A hospital acquired infection (HAI), also called a nosocomial infection, is a disease acquired in clinical surroundings, such as hospitals, nursing homes, rehabilitation centers, etc. They are usually contracted from intensive care units (ICUs) or emergency rooms (ERs) due to the presence of infected patients, contaminated linens, air droplets, etc. HAIs can also be traced in the patient’s microbiome in cases where the skin’s protective layer comes in contact with possible threats of infection, particularly after surgical operations. Some common HAIs include pneumonia, primary bloodstream infections, urinary tract infections (UTI), etc.<\/p>\n

\"T423385492_g\"<\/p>\n

The global market for HAI testing is primarily driven by the growing incidences of hospital-acquired testing and continuous upgradation of the existing healthcare facilities. Moreover, various techniques are being adopted to prevent, diagnose, and monitor HAIs, including microarrays, real-time location systems (RTLSs), polymerase chain reaction (PCR), etc. Additionally, the launch of numerous stringent government regulations to penalize healthcare facilities with high incidences of HAIs, is also acting as a growth inducing factor. All of these above-mentioned factors will continue to drive the global market for HAI testing in the coming years.<\/p>\n

Hospital Acquired Disease Testing Market <\/strong>2021-2026 Competitive Analysis and Segmentation:<\/strong><\/p>\n

Competitive Landscape With Key Players:<\/strong><\/p>\n

The competitive landscape of the hospital acquired disease testing market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

Key Market Segmentation:<\/strong><\/p>\n

The report has segmented the hospital acquired disease testing market on the basis of indication and region.<\/p>\n

Breakup by Indication:<\/strong><\/p>\n